ArticleCommunications medicine2026

Effectiveness, immunogenicity and safety of monovalent DS-5670a and bivalent DS-5670a/b SARS-CoV-2 vaccines: results from two randomized, active-comparator, non-inferiority trials.

Shunsuke Hamada et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.